Chapter 19 – Strategic Performance Measurement: Investment Centers
19–59
19-47 EVA® NOPAT and EVA® Capital; Financing Approach (45-60
Minutes)
1. Students should understand that EVA® is an approximation of an
entity’s true (i.e., “economic”) profits for a period. This measure of
profitability is defined as the difference between the entity’sNOPAT (net
operating profits after tax) and an imputed capital charge. NOPAT is
supposed to approximate the entity’s actual cash yield generated for
investors from recurring business activities during the period. The
amount of capital employed is supposed to represent the cash that
investors have put at risk in the firm, and upon which they expect an
appropriate return.To estimate both NOPAT and the amount of capital
for a period, the analyst begins with reportedfinancial-statement
amounts and then makes adjustments. These adjustments, in the
parlance ofEVA®, are collectively referred to as “equity equivalent
adjustments.”
The financing approach to estimating EVA® NOPAT begins with the
reported amount of income available to common shareholders. To this
amount, adjustments are made to eliminate financingeffects (distortions)
and accounting distortions (such as LIFO reserve adjustments and
adjustmentsregarding Deferred Income Taxes). The financing approach
to estimating EVA capital consists of adding together interest-bearing
debt + equity in the firm.
1. EVA® NOPAT—Financing Approach:
Income available to common
Plus: Equity-Equivalent (EE) Adjustments:
Increase in Deferred Tax account (1)
Increased in LIFO Reserve (2)
Adjusted Income to Common
Reported Interest Expense
Imputed Interest—Leases (3)
Tax Savings (Foregone) on Interest (4)
Interest Expense after Income Tax Effects